Access the full text.
Sign up today, get DeepDyve free for 14 days.
Jianming Zhang, Priscilla Yang, N. Gray (2009)
Targeting cancer with small molecule kinase inhibitorsNature Reviews Cancer, 9
Shuqiang Li, Jianguo Zhu, Weili Zhang, Youren Chen, Ke Zhang, L. Popescu, Xinliang Ma, Wayne Lau, R. Rong, Xueqing Yu, Bingbing Wang, Yafeng Li, C. Xiao, Mingming Zhang, Shuyan Wang, Liping Yu, Alex Chen, Xin-chun Yang, Jun Cai (2011)
Signature microRNA Expression Profile of Essential Hypertension and Its Novel Link to Human Cytomegalovirus InfectionCirculation, 124
A. Shkoda, J. Town, J. Griese, Michael Romio, H. Sarioglu, T. Knöfel, Fabian Giehler, A. Kieser (2012)
The Germinal Center Kinase TNIK Is Required for Canonical NF-κB and JNK Signaling in B-Cells by the EBV Oncoprotein LMP1 and the CD40 ReceptorPLoS Biology, 10
Zhikang Qian, Baoqin Xuan, T. Hong, Dong Yu (2008)
The Full-Length Protein Encoded by Human Cytomegalovirus Gene UL117 Is Required for the Proper Maturation of Viral Replication CompartmentsJournal of Virology, 82
Fengchun Ye, Fuchun Zhou, R. Bedolla, T. Jones, Xiu-fen Lei, Tao Kang, M. Guadalupe, Shou-Jiang Gao (2011)
Reactive Oxygen Species Hydrogen Peroxide Mediates Kaposi's Sarcoma-Associated Herpesvirus Reactivation from LatencyPLoS Pathogens, 7
M. Cannon, D. Schmid, T. Hyde (2010)
Review of cytomegalovirus seroprevalence and demographic characteristics associated with infectionReviews in Medical Virology, 20
M. Reeves, Abagail Breidenstein, T. Compton (2011)
Human cytomegalovirus activation of ERK and myeloid cell leukemia-1 protein correlates with survival of latently infected cellsProceedings of the National Academy of Sciences, 109
Robert Johnson, S. Huong, E. Huang (2000)
Activation of the Mitogen-Activated Protein Kinase p38 by Human Cytomegalovirus Infection through Two Distinct Pathways: a Novel Mechanism for Activation of p38Journal of Virology, 74
J. Zaborowska, S. Baumli, C. Laitem, Dawn O’Reilly, Peter Thomas, P. O’Hare, Shona Murphy (2014)
Herpes Simplex Virus 1 (HSV-1) ICP22 Protein Directly Interacts with Cyclin-Dependent Kinase (CDK)9 to Inhibit RNA Polymerase II Transcription ElongationPLoS ONE, 9
Seungtaek Kim, H. Ishida, D. Yamane, M. Yi, D. Swinney, S. Foung, S. Lemon (2013)
Contrasting Roles of Mitogen-Activated Protein Kinases in Cellular Entry and Replication of Hepatitis C Virus: MKNK1 Facilitates Cell EntryJournal of Virology, 87
(2007)
Varicella-zoster virus infection of human fibroblast cells activates the c-Jun Nterminal kinase pathway
L. Terry, Livia Vastag, J. Rabinowitz, T. Shenk (2012)
Human kinome profiling identifies a requirement for AMP-activated protein kinase during human cytomegalovirus infectionProceedings of the National Academy of Sciences, 109
A. Bode, Z. Dong (2007)
The functional contrariety of JNKMolecular Carcinogenesis, 46
Q. Qin, R. Penkert, R. Kalejta (2013)
Heterologous Viral Promoters Incorporated into the Human Cytomegalovirus Genome Are Silenced during Experimental LatencyJournal of Virology, 87
Baoqin Xuan, Zhikang Qian, E. Torigoi, Dong Yu (2009)
Human Cytomegalovirus Protein pUL38 Induces ATF4 Expression, Inhibits Persistent JNK Phosphorylation, and Suppresses Endoplasmic Reticulum Stress-Induced Cell DeathJournal of Virology, 83
M. Bogoyevitch, B. Kobe (2006)
Uses for JNK: the Many and Varied Substrates of the c-Jun N-Terminal KinasesMicrobiology and Molecular Biology Reviews, 70
F. Martínez, Ruth Cruz, Fang Lu, Robert Plasschaert, Z. Deng, Yisel Rivera-Molina, M. Bartolomei, P. Lieberman, Qiyi Tang (2014)
CTCF Binding to the First Intron of the Major Immediate Early (MIE) Gene of Human Cytomegalovirus (HCMV) Negatively Regulates MIE Gene Expression and HCMV ReplicationJournal of Virology, 88
Laura Chico, L. Eldik, D. Watterson (2009)
Targeting protein kinases in central nervous system disordersNature Reviews Drug Discovery, 8
Claudia Santos, L. Stangherlin, E. Figueiredo, Clemar Corrêa, M. Teixeira, M. Silva (2014)
High prevalence of HCMV and viral load in tumor tissues and peripheral blood of glioblastoma multiforme patientsJournal of Medical Virology, 86
W. Nacken, C. Ehrhardt, S. Ludwig (2012)
Small molecule inhibitors of the c-Jun N-terminal kinase (JNK) possess antiviral activity against highly pathogenic avian and human pandemic influenza A viruses, 393
D. Hargett, T. McLean, S. Bachenheimer (2005)
Herpes Simplex Virus ICP27 Activation of Stress Kinases JNK and p38Journal of Virology, 79
S. Manicklal, V. Emery, T. Lazzarotto, S. Boppana, Ravindra Gupta (2013)
The “Silent” Global Burden of Congenital CytomegalovirusClinical Microbiology Reviews, 26
Maorong Xie, Baoqin Xuan, J. Shan, Deng Pan, Yamei Sun, Zhao Shan, Jinping Zhang, Dong Yu, Bin Li, Zhikang Qian (2014)
Human Cytomegalovirus Exploits Interferon-Induced Transmembrane Proteins To Facilitate Morphogenesis of the Virion Assembly CompartmentJournal of Virology, 89
Heidi Zapata, M. Nakatsugawa, J. Moffat (2006)
Varicella-Zoster Virus Infection of Human Fibroblast Cells Activates the c-Jun N-Terminal Kinase PathwayJournal of Virology, 81
Anna Pereira, J. Soares-Martins, F. Leite, André Cruz, Alice Torres, T. Souto-Padrón, E. Kroon, P. Ferreira, C. Bonjardim (2011)
SP600125 inhibits Orthopoxviruses replication in a JNK1/2 -independent manner: Implication as a potential antipoxviralAntiviral Research, 93
Human cytomegalovirus (HCMV) is an opportunistic pathogen that causes severe diseases in congenitally infected newborns and immunocompromised patients. Currently, no vaccine is available to prevent HCMV infection. Anti‐viral drugs are limited by their side effects and drug resistance. In this study, by performing a medium‐sized, anti‐HCMV chemical screening, we identified SP600125, CC‐401, and the c‐Jun N‐terminal kinase (JNK) inhibitor VIII, three structurally different small molecule JNK inhibitors that effectively inhibited HCMV replication in cultured human fibroblasts (HFs). SP600125 showed its potential by inhibiting the viral replication of a HCMV laboratory strain in HFs and a HCMV clinical strain in human retinal pigment epithelial cells. Knockdown of JNK expression by RNA interference significantly impaired HCMV replication, mimicking the effect of the chemical inhibitors on virus infection. Mechanistically, SP600125 affects a very early step of the viral life cycle. Viral binding, entry, and the delivery of viral DNA into the cells were not inhibited by the compound. Instead, it suppressed the transcription of the immediate‐early viral genes IE1/2 and the accumulation of their gene products. IE1/2 are among the first genes expressed after viral entry, and they are the master regulators of late phase viral gene expression. Consistent with this notion, the expression of other viral genes was also reduced after SP600125 treatment. We propose that JNK inhibitors have the potential to become a new class of anti‐HCMV drug candidates, and JNK is a feasible target for the development of anti‐HCMV drugs. J. Med. Virol. 87:2135–2144, 2015. © 2015 Wiley Periodicals, Inc.
Journal of Medical Virology – Wiley
Published: Jan 1, 2015
Keywords: ; ; ;
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.